In Romania, an increase in the notification of human immunodeficiency virus (HIV) infections among people who inject drugs (PWID) was reported between 2011 and 2013; however, this decreased over the period 2014-17. Recent data based on self-reported HIV status among drug treatment clients suggest that around 16 % reported to be HIV positive. However, self-reported prevalence is likely an underestimate, as some drug users might not know their status. The 2017 seroprevalence study in Bucharest found that 30 % of injectors were HIV positive.
|Data from 2017 (HIV) and from 2015 (HCV).|
Hepatitis C virus (HCV) infection is common among Romanian drug users. The seroprevalence study conducted in 2017 among PWID in Bucharest indicated that more than three quarters tested positive for HCV antibodies and that fewer than 1 in 10 were infected with hepatitis B virus. HIV and HCV co-infections are frequent among PWID in Romania.